Performance of longitudinal item response theory models in shortened or partial assessments

por Arrington, Leticia, Ueckert, Sebastian, Ahamadi, Malidi, Macha, Sreeraj, Karlsson, Mats O.
Publicado 2020

Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes

por Baron, Kyle T., Macha, Sreeraj, Broedl, Uli C., Nock, Valerie, Retlich, Silke, Riggs, Matthew
Publicado 2016

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus

por Heise, Tim, Seman, Leo, Macha, Sreeraj, Jones, Peter, Marquart, Alexandra, Pinnetti, Sabine, Woerle, Hans J., Dugi, Klaus
Publicado 2013

The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study

por Ring, Arne, Brand, Tobias, Macha, Sreeraj, Breithaupt-Groegler, Kerstin, Simons, Gudrun, Walter, Beate, Woerle, Hans J, Broedl, Uli C
Publicado 2013

Quantitative systems pharmacology in neuroscience: Novel methodologies and technologies

por Bloomingdale, Peter, Karelina, Tatiana, Cirit, Murat, Muldoon, Sarah F., Baker, Justin, McCarty, William J., Geerts, Hugo, Macha, Sreeraj
Publicado 2021

Population pharmacokinetics of letermovir following oral and intravenous administration in healthy participants and allogeneic hematopoietic cell transplantation recipients

por Prohn, Marita, Viberg, Anders, Zhang, Da, Dykstra, Kevin, Davis, Casey, Macha, Sreeraj, Sabato, Philip, de Alwis, Dinesh, Iwamoto, Marian, Fancourt, Craig, Cho, Carolyn R.
Publicado 2021

Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis

por Conrado, Daniela J., Nicholas, Timothy, Tsai, Kuenhi, Macha, Sreeraj, Sinha, Vikram, Stone, Julie, Corrigan, Brian, Bani, Massimo, Muglia, Pierandrea, Watson, Ian A., Kern, Volker D., Sheveleva, Elena, Marek, Kenneth, Stephenson, Diane T., Romero, Klaus
Publicado 2017

Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's Disease

por Romero, Klaus, Conrado, Daniela, Burton, Jackson, Nicholas, Timothy, Sinha, Vikram, Macha, Sreeraj, Ahamadi, Malidi, Cedarbaum, Jesse, Seibyl, John, Marek, Kenneth, Basseches, Peter, Hill, Derek, Somer, Ed, Gallagher, Jill, Dexter, David T., Roach, Arthur, Stephenson, Diane
Publicado 2019